Ben Tre Pharmaceutical JSC (HOSE: DBT)
Vietnam
· Delayed Price · Currency is VND
12,400
+150 (1.22%)
At close: Nov 20, 2024
DBT Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | 2014 - 2010 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '20 Jun 30, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | 2014 - 2010 |
Net Income | 16,892 | 21,396 | 20,193 | 28,737 | 23,662 | 22,203 | Upgrade
|
Depreciation & Amortization | 13,020 | 13,336 | 13,007 | 11,778 | 4,541 | 3,859 | Upgrade
|
Loss (Gain) From Sale of Assets | -89.55 | - | - | -29,404 | -4,561 | -24,273 | Upgrade
|
Other Operating Activities | 13,929 | -7,223 | -4,208 | -2,363 | -6,510 | 530.03 | Upgrade
|
Change in Accounts Receivable | -6,034 | 11,450 | -44,032 | 14,561 | -17,611 | -93,093 | Upgrade
|
Change in Inventory | -152,117 | -104,463 | 18,380 | 7,526 | 20,591 | -5,054 | Upgrade
|
Change in Accounts Payable | 40,699 | -9,390 | 914.59 | 5,104 | 18,802 | 35,485 | Upgrade
|
Change in Other Net Operating Assets | -1,070 | 776.47 | -15,069 | 15,135 | -6,207 | 113.14 | Upgrade
|
Operating Cash Flow | -74,770 | -74,118 | -10,814 | 51,072 | 32,706 | -60,230 | Upgrade
|
Operating Cash Flow Growth | - | - | - | 56.16% | - | - | Upgrade
|
Capital Expenditures | -6,167 | -6,822 | -10,513 | -9,016 | -4,496 | -1,173 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | 7,534 | 14,932 | - | - | Upgrade
|
Investment in Securities | -19,327 | -28,148 | 2,557 | -31,676 | -32,237 | 32,732 | Upgrade
|
Other Investing Activities | 5,790 | 6,570 | 8,519 | 7,175 | 579.55 | 2,756 | Upgrade
|
Investing Cash Flow | -36,154 | -42,400 | 8,097 | -53,129 | -33,288 | 34,315 | Upgrade
|
Short-Term Debt Issued | - | - | - | 572,220 | 410,000 | - | Upgrade
|
Long-Term Debt Issued | - | 697,476 | 538,385 | - | - | 432,682 | Upgrade
|
Total Debt Issued | 533,010 | 697,476 | 538,385 | 572,220 | 410,000 | 432,682 | Upgrade
|
Short-Term Debt Repaid | - | - | - | -564,853 | -404,801 | - | Upgrade
|
Long-Term Debt Repaid | - | -592,327 | -537,279 | - | - | -368,659 | Upgrade
|
Total Debt Repaid | -443,304 | -592,327 | -537,279 | -564,853 | -404,801 | -368,659 | Upgrade
|
Net Debt Issued (Repaid) | 89,706 | 105,148 | 1,106 | 7,367 | 5,199 | 64,023 | Upgrade
|
Issuance of Common Stock | 12,143 | 12,143 | - | 34,598 | - | - | Upgrade
|
Repurchase of Common Stock | -22.1 | -97.85 | - | - | - | - | Upgrade
|
Common Dividends Paid | -4,176 | -13,529 | -18,343 | -12,276 | -7,681 | -6,999 | Upgrade
|
Financing Cash Flow | 97,651 | 103,665 | -17,237 | 29,689 | -2,481 | 57,024 | Upgrade
|
Net Cash Flow | -13,273 | -12,853 | -19,954 | 27,633 | -3,063 | 31,109 | Upgrade
|
Free Cash Flow | -80,937 | -80,940 | -21,328 | 42,056 | 28,210 | -61,403 | Upgrade
|
Free Cash Flow Growth | - | - | - | 49.08% | - | - | Upgrade
|
Free Cash Flow Margin | -9.77% | -10.11% | -2.63% | 5.26% | 4.86% | -11.12% | Upgrade
|
Free Cash Flow Per Share | -4543.59 | - | - | 2613.12 | 2287.19 | -5513.80 | Upgrade
|
Cash Interest Paid | 15,165 | 15,165 | 14,031 | 11,178 | 9,632 | 9,194 | Upgrade
|
Cash Income Tax Paid | - | 3,736 | 3,117 | 8,026 | 9,804 | 4,623 | Upgrade
|
Levered Free Cash Flow | -146,623 | -87,108 | 3,759 | -34,583 | 87,277 | -73,019 | Upgrade
|
Unlevered Free Cash Flow | -135,070 | -77,618 | 12,015 | -27,597 | 93,408 | -67,272 | Upgrade
|
Change in Net Working Capital | 160,448 | 102,641 | 7,536 | 49,800 | -72,871 | 72,302 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.